Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves Β· freshest Wall Street data, updated daily View live feed β†’
Analyst Tracker/Harry Gillis
BER

Harry Gillis

Wall Street Analyst
β˜…β˜…β˜…β˜…β˜…
#50
on 13Foresight Β· ranked by our own returns
74%
Success Rate
+10.9%
Average Return
29 of 39 calls profitable Β· +23.8% vs benchmark
S&P 500 (SPY)
πŸ“ˆ Across the calls we could measure, roughly 74% of Harry Gillis's ratings turned a profit when each position was held for 1 year β€” averaging +10.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

49 Buy 15 Hold 0 Sell
Harry's Stock Coverage 8 ratings Β· 2026-11-12
Company Date Position Consensus β“˜ Price Target β“˜ 1-Yr Return vs S&P 500 β“˜
DE:FRE
Fresenius SE & Co. KGaA
Oct 23, 2026 BUY Strong Buy
+8.4% avg upside
21 analysts
$54.00
13.02% Upside
+13.0% Β·
QGEN
Qiagen
Oct 22, 2026 HOLD Buy
-10.5% avg upside
25 analysts
$52.11
3.82% Upside
-0.2% Β·
SE:SOBI
Swedish Orphan Biovitrum AB
Oct 19, 2026 BUY Strong Buy
-7.0% avg upside
7 analysts
$570.00
16.35% Upside
+11.2% Β·
BNTX
BioNTech SE
Oct 07, 2026 BUY Strong Buy
+48.9% avg upside
28 analysts
$140.00
58.80% Upside
-9.3% Β·
DE:SRT3
Sartorius
Oct 07, 2026 BUY Strong Buy
-0.2% avg upside
19 analysts
$280.00
4.09% Downside
+17.5% Β·
CH:TECN
Tecan Group AG
Oct 02, 2026 BUY Buy
+36.3% avg upside
9 analysts
$300.00
21.53% Upside
+5.8% Β·
DE:FME
Fresenius Medical Care AG & Co. KGaA
Sep 29, 2026 HOLD Hold
+22.7% avg upside
24 analysts
$42.00
4.04% Upside
+6.7% Β·
MRNA
Moderna
Sep 10, 2026 HOLD Hold
-48.5% avg upside
38 analysts
$100.00
54.98% Downside
+69.3% Β·
πŸ”’ 3 more ratings β€” with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Harry Gillis β€” Frequently Asked Questions
How accurate are Harry Gillis's stock ratings?
Based on the calls 13Foresight could measure, about 77% of Harry's ratings were profitable over a one-year hold, with an average return of +11.2% per rating, or +10.3% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Harry ranked on 13Foresight?
Harry Gillis is currently ranked #50 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge β€” so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Harry cover?
Harry most recently has ratings on DE:FRE, QGEN, SE:SOBI, BNTX, DE:SRT3, CH:TECN, DE:FME, MRNA. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.